A sensitive, optimized assay for serum AMP deaminase (EC 3.5.4.6) is presented, which is based on a colorimetric indophenol determination of ammonia liberated during the enzyme reaction. An average enzyme activity in serum of 2.7 U/liter (n 36, range 0-6.2) for healthy adults was established. Both the enzyme and colorimetric reactions were optimized to give an assay sensitivity of 0.2 U/liter of serum, a 98-99% analytical recovery in the normal serum enzyme concentration range, and a CV of 7.9%
by the high rate of spontaneous mutation with which Duchenne muscular dystrophy is believed to be associated (9) .
For these reasons, the screening of suspected carriers iswidely encouraged (10, 11 ) but only partly successful.
We believe that another enzyme-AMP deaminase (AMP aminohydrolase, EC 3.5.4.6)-which is highly specific for skeletal muscle (12), may offer a suitable alternative (or adjunct) to serum creatine kinase determination in Duchenne muscular dystrophy carriers.
It catalyzes the reaction
AMP + H2O -IMP + NH3
as part of the purine nucleotide cycle reported by Lowenstein (12) . In addition to its tissue specificity, its activity is relatively high in normal skeletal muscle (13) and decreased in Duchenne muscular dystrophy (14, 15) . This decrease is characteristic of many muscle enzymes associated with glycolysis and energy transfer in dystrophy, but a significant increase in serum activity, frequently associated with tissue decrease, has not previouslybeen demonstrated for AMP deaminase. We report here the development of a very sensitive, optimized assay for serum AMP deaminase and the establishment of a normal range. Preliminary results suggest substantially increased activity in serum in Duchenne muscular dystrophy, a variety of other myopathies,
and Duchenne muscular dystrophy carriers (manuscript in preparation).
Materials and Methods

Reagents
Rabbit muscle AMP deaminase (grade IV; Sigma Chemical Co., St. Louis, Mo. 63187) was shipped in glycerol/water (66/34 by vol), 0.33 mol/liter KC1, pH 7.4, at 4 #{176}C. The enzyme was stored at -20 #{176}C in 50 mmol/ liter sodium citrate buffer, pH 6.50, 1 mol/liter KC1, and 1 mmol/liter 2-mercaptoethanol.
Sodium AMP (yeast, Type II), Na2ATP (equine muscle), imidazole, and adenosine (Sigma grade, anhydrous)
were also from Sigma. Na AMP, Na2ATP, and adenosine were stored at -20 #{176}C until used. Grade A dithiothreitol was from Calbiochem, La Jolla, Calif. 92037. "Rapid-Stat" inorganic orthophosphate assay kits were purchased from Pierce Chemical Co., Rockford, Ill. 61105. The alkaline hypochiorite solution used was a commercial household bleach (5.25% solution of NaOC1). All other materials were analytical reagent grade. Ammonia-free water was prepared by passing distilled water through Aliquots of pooled hospital serum were stored at -20 #{176}C until needed during the course of assay development.
To establish a normal range, we took blood samples from healthy adults, centrifuged, and stored the serum at 4 #{176}C. Plain, silicone-coated, evacuated glass tubes were used for the collection and assays were run within 3 h of collection.
Assay for Ammonia
An 53 mmol/liter sodium citrate buffer (pH 6.20, z = 0.270), was prepared from dried anhydrous citric acid and 1 mol/liter NaOH. A stock 1 mol/liter NaAMP aqueous substrate solution was adjusted to pH 6. 20 with NaOH and aliquots were frozen until needed. Concentration was confirmed spectrophotometrically at 259 nm after appropriate dilution. Ammonia production was assayed by a modification of the Chaney and Marbach indophenol method (16- 
18). Optimum concentrations
of the indophenol reaction reagents for maximum sensitivity to ammonia were established simultaneously by using a simplex optimization procedure (19, 20) . The initial reagent concentrations were those specified in the method modification of Belfield et al. ( 1 7). There were four variables, and step sizes(expressedas concentrations in the initial stock reagents)were: phenol, 8.0 g/liter; NaOH, 80 mmol/liter;sodium nitroprusside, 40 mg/liter;and commercial bleach (5.25% NaOCl), 4 ml/liter. Twenty-four steps were taken and optimization was reached at step 19 (data not shown).
On the basis of these results, a working phenol-nitroprusside solution was prepared from 15.25 g of crystalline phenol and 708 mg of sodium nitroprusside in 250 ml of water. Alkaline hypochlorite solution contamed 150 mmol of NaOH and 7.2 ml of liquid household bleach (5.25% NaOC1) diluted to 250 ml with water. Both reagents were stored at 4 #{176}C in brown glass bottles. Reported stability is six weeks (17) .
Stock 2.000 mol/liter ammonia standard was prepared from 0.1322 g of dried (100 #{176}C, 4 h) (NH4)2SO4 diluted to 1 liter. The solution was stored at 4 #{176}C throughout.
The optimized assay protocol appears in Table 1 . Developed color was measured at 630 nm, the maximum absorption wavelength of indophenol at the assay pH. A serum control was run with each sample to correct for the background ammonia present in serum. AMP was added to these controls after quenching to correct for the slight increase that AMP imparts to the final absorbance (about 0.001 A per 1.0 mmol of AMP per liter).
AMP Deaminase Reaction Optimization
To study the effect of pH on the enzyme reaction, an 0.05 mol/liter sodium citrate buffer (pH 6.00, 25 #{176}C) was prepared. NaOH was added and 5-mi aliquots were taken at 0.05 pH unit intervals up to pH 6.67. Assays were then run according to Table 1 , at 37 #{176}C. The reported pH is that of the final reaction mixture at enzyme reaction time t0, 25 #{176}C, as determined from reaction duplicates.
We measured the effect of ionic strength on the enzyme reaction by preparing a stock 22 mmol/liter citrate buffer ( = 0.120, pH 6.20) and adding appropriate volumes of aqueous stock 2.000 mol/liter KC1 to buffer aliquots to provide a graduated series of solutions of increasing ionic strength. The pH of each was readjusted with negligible volumes of NaOH to 6.20. Final ionic strength of the assay reaction mixtures, allowing for dilution and the NaAMP substrate present, ranged between 0.179 and 0.454. We then assayed serum AMP deaminase, using the protocol of Table 1 .
Adenosine Deaminase Assay
Serum adenosine deaminase (adenosine aminohydrolase, EC 3.5.4.4) was determined by substituting a 4.0 mmol/liter saturating concentration (21 ) of adenosine for NaAMP substrate and using the protocol of Table 1 , otherwise unchanged.
Phosphatase Activity
We determined phosphatase activity on substrate AMP by measuring inorganic orthophosphate production. A Pierce "Rapid-Stat" kit, which makes use of a method based on the formation of a reduced phosphomolybdate chromogen, was used. Both citrate and AMP were observed to decrease color development, 0.020
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Fresh Na2ATP stock solution was prepared in sodium citrate buffer, pH 6.20, to a final concentration of 20 mmol/liter and confirmed spectrophotometrically at 259 nm. The solution was made fresh daily and kept on crushed ice. Working aliquots of various concentrations were prepared by dilution with buffer as required. We assayed for the effect of ATP on serum AMP deaminase activity according to Table 1 , with ATP/buffer solution substituting for buffer alone where appropriate. Dithiothreitol was kept at 4 #{176}C throughout. Fresh 2-mercaptoethanol and dithiothreitol solutions were each prepared in citrate buffer, pH 6.2, to final concentrations of 2.0, 5.0, and 8.0 mmol/liter. The protocol was altered to allow for a 45-mm incubation of sera in these buffers before substrate addition.
Results
Serum AMP Deaminase Activity
Buffer.
Several buffers were considered for use.
Phosphate was excluded because a wide variety of inorganic and organic substances competitively inhibit AMP deaminase activity (22, 23) . This inhibition is countered at saturating substrate concentration (13), but it was considered to be an inherently poor choice nonetheless.
Tris.HC1 has a color-quenching effect on the indophenol reaction (24) and has a pK'0 of two units above the reaction pH optimum, so it is unsuitable. We found that imidazole also interferes significantly with color development at 0.1 mol/liter concentration. Succinate buffer has a pK'a too low for optimum buffer capacity in the 6.0-6.8 range, although it has been frequently used in studies of AMP deaminase. Citrate was selected because its of 5.67 at 53 mmol/liter is reasonably close to reaction pH and its ffect on indophenol color development negligible. Sodium and potassium ions activate the human muscle enzyme to about the same optimal extent (13); therefore sodium was arbitrarily chosen as the cation.
Serum concentration.
Enzyme activity was linear with serum concentration between 0.0 and 83 tl of serum per milliliter of reaction volume (Figure 1) (Figure 2 ) to be 1.4 X 10 mol/liter, agreeing well with a value previously reported for the isolated human skeletal muscle enzyme at pH 6.5 in imidazole buffer (25) pH. Optimum serum enzyme activity occurred around pH 6.21 (Figure 3) , and pH 6.20 was therefore selected. The change in pH during the reaction was about +0.002/mm.
Ionic strength.
Optimum serum enzyme activity in the assay occurred when total ionic strength was 0.295-0.320 (Figure 4 ). There was a rather rapid decrease in activity on either side of this plateau. A value of 0.300 was chosen.
Reaction time. AMP deaminase activity was constant between 0 and 60 mm ( Figure 5 ). Thirty minutes was chosen for routine use in the assay, to provide both a 
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Serum effect on AMP deaminase activity. No significant inhibition of commercial rabbit muscle AMP deaminase activity by pooled human serum under protocol conditions was found (Table 2) .
Potentially interfering enzyme reactions.
The generation of ammonia from the AMP substrate by a coupled reaction of serum 5'-nucleotidase (EC 3.1.3.5) and adenosine deaminase suggests itself as a potential interference in the assay. This would give falsely elevated valuesforapparentAMP deaminase activity. The total phosphatase activity in pooled serum under AMP deaminase assay conditions was 2.4 U/liter. The corresponding rate of adenosine production would have this value as an upper limit, because some of the measured phosphate could arise from dephosphorylation of other serum organic phosphate compounds by vanous phosphatases.
Activity of adenosine deaminase under the same reaction conditions, but with adenosine substituting for AMP, was 12.3 U/liter. Because both enzymes were active in serum under AMP deaminase assay conditions, even though these conditions are not optimal for either enzyme (28, 29) , it was important to calculate the effect of their coupled activity on ammonia concentration during the 30-mm AMP deaminase reaction period.
Several assumptions were necessary. We assumed that virtually no adenosine is present in serum at t0, and therefore that all adenosine available for deamination results from phosphatase activity. The Km for human adenosine deaminase was taken to be 7.3 X 10 mol/ liter (21 ). The increase in adenosine concentration was equated with phosphate increase, even though this may assign too high a value to 5'-nucleotidase activity. Finally, saturating conditions for the 5'-nucleotidase reaction, non-saturating conditions for that of adenosine deaminase, and Michaelis-Menten kinetics were assumed.
One can then calculate from the appropriate rate equations for the two reactions that 6.5 X 1011 mol of ammonia was produced by the coupled activity in the reaction vessel during 30 mm. This represents an apparent AMP deaminase activity of about 0. 1 U/liter serum. An interference of this magnitude is not considered significant, because it is less than the standard deviation in the precision of the method and below the limit of assay sensitivity, as discussed below. Diversion of substrate AMP by the activity of phosphatases would represent a decrease of 2.0 X 106 mol/liter in AMP concentration during the 30-mm assay. This is negligible, 0.01% of the total substrate present at t0.
Potential activators. Although ATP has an activating effect on AMP deaminase activity at physiological AMP concentrations in skeletal muscle (about 5 mmolfliter) (13, 26, 30) , it reportedly inhibits activity when the substrate is saturating (31 ). Our results substantiate this inhibition with increasing ATP concentrations ( Figure   6 ). ATP was therefore not included in the assay protocol.
No increase in enzyme activity was found with either dithiothreitol or 2-mercaptoethanol addition. Furthermore, both reagentshave a color-quenching effect on the indophenol reaction, thereby decreasing the assay sensitivity to ammonia.
Enzyme stability. Serum AMP deaminase stability at 4 #{176}C and at -20 #{176}C as measured according to the protocol and expressed as a percentage of initial activity is shown in Figure 7 . The enzyme loses about 10% of its activity in the first 24 h of refrigeration, but is then relatively stable until day 4. The enzyme in frozen serum loses less than 10% of its activity immediately and is then reasonably stable for about four weeks. the highest serum ammonia concentration seen during the course of our investigations.
Time for color development. Indophenol color development at 37 #{176}C was complete within 10 mm after alkaline hypochlorite reagent was added ( Figure 9 ). Color was stable for at least 1 h.
Sensitivity.
A change of 0.001 in indophenol absorbance corresponds to a change in ammonia concentration of 4.0 X 108 mol/liter. This is therefore the lower detection limit of the method with most instruments, equal to 6.9 X 10'#{176}g of NH3/g of H20 (or 0.20 U/liter serum AMP deaminase activity). These values represent a 59% lower reaction detection limit as compared with results obtained before simplex optimization of the indophenol reagent concentrations. Reliability and a Normal Range
Accuracy. Accuracy of the entire assay protocol, as measured by recovery of ammonia added to serum in the form of (NH4)2SO4, is detailed in Precision. The precision of this assay was measured in-run on a single serum specimen, and between-run over a period of three weeks with aliquots from the same serum pool but differing reagent preparations.
The results appear in Table 5 . No significant sex-related difference is seen, and there was no significant correlation between serum AMP deaminase and age.
Discussion
No method for serum AMP deaminase determination has previously been reported. We have therefore developed an accurate, precise, and highly sensitive assay and have established a normal range of activity in serum of healthy adults. This assay is based on a colonimetnic quantitation of ammonia produced in a 30-mm enzyme reaction period at 37 #{176}C. The spectrophotometric method of Kalckar (32) is more direct but is insufficiently sensitive for use on the activities of AMP deaminase found in serum.
The enzyme assay was made optional on a system consisting initially of sodium citrate buffer (0.10 mol/ liter, pH 6.5) and a 5 mmol/liter final concentration of substrate AMP. Each variable except temperature was made optimal and then all experiments were rerun under these derived optimum conditions to ensure that earlier results remained valid.
An elegant, less tedious, and statistically sound method of simultaneously optimizing all continuous variables in an analytical procedure-the simplex optimization process (19)-was used to lower the detection limit of the indophenol reaction to ammonia.
We found the activity of AMP deaminase in normal serum to be low in comparison with that of some other clinically useful enzymes. This may reflect a slow efflux of AMP deaminase from the cell, either because of its probablehigh molecular weight or its close association with muscle myosin (33). Alternatively, it may represent an unusually high sensitivity of the enzyme to proteolytic inactivation within the cell itself or in the serum afterefflux.
It therefore seemed worthwhile to explore the effect of various possible enzyme activators. However, all trials proved ineffective. For example, AlP, which is reported to activate the enzyme in vitro at low substrate concentrations (13) , shows an inhibitory effect in our assay when AMP is present in saturating amounts.
Furthermore, we find no measurable increase in activity when either dithiothreitol or 2-mercaptoethanol is incubated with the buffered serum sample before assay. Thiol-group protectors have been used in the published preparative methods (34, 35), but the necessity for them is put into question by recent evidence that either of two thiol-blocking reagents, N-ethylmaleimide or 5,5'-dithiobis(2-nitrobenzoate), do not inactivate the enzyme when reacted with the six exposed thiol groups in native rat skeletal muscle AMP deaminase (36).
Incubation of commercially-prepared rabbit muscle AMP deaminase with human serum does not affect enzyme activity, suggesting that no AMP-deaminase inhibitory factor is present in normal serum. The linearity of enzyme activity with reaction time is evidence that there is no appreciable temperature mactivation of the enzyme at 37 #{176}C during the 30-mm assay.
However, the enzyme stability is highly related to sample storage temperature.
On refrigeration there is an average loss of activity of 10% in 24 h, but freezing at -20 #{176}C maintains stability for about four weeks.
Interference from the coupled 5'-nu#{233}leotidase/ adenosine deaminase reactions discussed above could be a problem. We calculate that this interference is not important when the activities of these enzymes in serum are normal. However, increased activity of either enzyme would increase ammonia production and thus cause a falsely elevated value for apparent AMP deaminase activity. We are therefore searching for some method of eliminating the potential for this effect.
Finally, it should be noted that the normal range established by our procedure does not display a gaussian distribution (not an uncommon situation) and therefore that the customary method for calculation of a standard deviation is not applicable. Preliminary data, not included here, also suggest that there is no significant correlation between serum AMP deaminase and creatine kinase activities in these 30 normal samples.
